Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Oyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PO. 2006 Oct. Proc Natl Acad Sci U S A.103(44):16466-71. Epub 2006 Oct 20.

Protein disulfide isomerase expression is related to the invasive properties of malignant glioma.

Goplen D, Wang J, Enger PO, Tysnes BB, Terzis AJ, Laerum OD, Bjerkvig R. 2006 Oct. Cancer Res.66(20):9895-902.

Cell therapies for glioblastoma.

Terzis AJ, Niclou SP, Rajcevic U, Danzeisen C, Bjerkvig R. 2006 Aug. Expert Opin Biol Ther.6(8):739-49.

The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease.

De Winter F, Vo T, Stam FJ, Wisman LA, Bar PR, Niclou SP, van Muiswinkel FL, Verhaagen J. 2006 May. Mol Cell Neurosci.32(1-2):102-17. Epub 2006 May 3.

Chemorepellent axon guidance molecules in spinal cord injury.

Niclou SP, Ehlert EM, Verhaagen J. 2006 Mar. J Neurotrauma.23(3-4):409-21.

A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.

Majed HH, Chandran S, Niclou SP, Nicholas RS, Wilkins A, Wing MG, Rhodes KE, Spillantini MG, Compston A. 2006 Feb. J Neurosci.26(6):1730-8.